Patient experience of telehealth appointments in head and neck cancer services during the COVID‐19 pandemic

Abstract

BackgroundThe COVID‐19 pandemic resulted in rapid changes to head and neck cancer (HNC) services. Multidisciplinary team (MDT) face‐to‐face appointments were converted to telehealth appointments (telephone and video‐call) to reduce the risk of COVID‐19 transmission. The literature exploring HNC patient experience of these appointment types is limited.AimsTo explore patient experience of telehealth appointments at one UK centre during the COVID‐19 pandemic, as well as the variables that may influence patient preference for virtual or face‐to‐face appointments.Methods & ProceduresA survey‐based study design was used, with closed questions and open text options to capture the views of the participants. Quantitative data were analysed using descriptive statistics. Open text data was used to add depth to the findings.Outcomes & ResultsA total of 23 participant surveys were returned. Six categories were identified: Usability; Information receiving & giving; Satisfaction; Emotions and comfort; Rapport; and Travel time and cost. Overall, participants gave positive responses to each category and indicated that telehealth appointments met their needs. Areas for clinical consideration are highlighted. Variables such as age, travel distance from hospital site, fear of COVID‐19 and information technology (IT) access did not appear to influence patient preference for appointment type.Conclusions & ImplicationsGoing forward, telehealth may be considered for use in combination with face‐to‐face appointments in the HNC pathway. Areas for further development include a ‘telehealth screening tool’ that may help to identify those patients most appropriate for these appointment types, or who require support to access them.WHAT THIS PAPER ADDSWhat is already known on this subject The COVID‐19 pandemic resulted in major disruption to HNC centres across the world. Services adapted to meet the needs of patients with many implementing telehealth into pathways. Studies exploring telehealth in speech and language therapy (SLT) services with the HNC population indicate positive results. It is clear telehealth has a role in modern healthcare and should not be viewed as a temporary solution to the pandemic. It is, however, recognized that embedding telehealth into pathways is not straightforward and requires ongoing review and evaluation, which includes patient and clinician perceptions.What this study adds to the existing knowledge The service evaluation gives insight into HNC patient experience of telehealth appointments for MDT clinics (led by SLT, dietician and clinical nurse specialist) during the COVID‐19 pandemic. Overall, patients report a positive experience of telehealth in the HNC pathway and are willing to accept this platform into their healthcare. Areas for clinical consideration are highlighted.What are the actual and clinical implications of this work? This findings of this service evaluation can be used to support the co‐design of HNC pathways which embed telehealth as an option for patients. Areas that were important to the participants are highlighted; this includes the timing of telehealth appointments in the pathway, the need to meet the MDT face to face and the positive benefit of cost savings. The authors suggest a telehealth appointment screening tool as an area for future development.

Genetic predisposition to milder forms of COVID-19 may provide some resilience to head and neck cancers

“…While the impact of COVID-19 on the well-being of patients with HNC is undeniable, the majority of studies conducted thus far have focused on the indirect effects of the SARS-CoV-2 pandemic on the HNC population, particularly through delays in the diagnosis and treatment of this condition ( 7 , 8 ). In contrast, our study has centered on investigating the relationship between genetic predisposition to various forms of COVID-19 and the risks of HNC.…”